Insider Selling: Nature’s Sunshine Products (NASDAQ:NATR) EVP Sells $41,360.00 in Stock

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) EVP Kevin Herbert sold 2,000 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $20.68, for a total transaction of $41,360.00. Following the completion of the transaction, the executive vice president owned 48,866 shares in the company, valued at approximately $1,010,548.88. The trade was a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Nature’s Sunshine Products Stock Performance

Nature’s Sunshine Products stock opened at $20.08 on Thursday. The firm’s 50-day moving average is $23.51 and its 200-day moving average is $23.80. Nature’s Sunshine Products, Inc. has a 1 year low of $12.97 and a 1 year high of $28.14. The company has a market cap of $353.01 million, a P/E ratio of 18.25 and a beta of 0.86.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.10. Nature’s Sunshine Products had a net margin of 4.06% and a return on equity of 14.67%. The company had revenue of $122.89 million for the quarter, compared to the consensus estimate of $122.15 million.

Analyst Ratings Changes

Several analysts recently issued reports on the company. DA Davidson reissued a “buy” rating and issued a $33.00 price target on shares of Nature’s Sunshine Products in a report on Monday, May 11th. Canaccord Genuity Group set a $37.00 price target on Nature’s Sunshine Products in a report on Friday, May 8th. Finally, Weiss Ratings downgraded Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Nature’s Sunshine Products currently has a consensus rating of “Moderate Buy” and an average target price of $35.00.

Institutional Trading of Nature’s Sunshine Products

Hedge funds have recently bought and sold shares of the company. State of Alaska Department of Revenue bought a new stake in Nature’s Sunshine Products in the 4th quarter valued at about $31,000. New York State Teachers Retirement System bought a new stake in Nature’s Sunshine Products in the 1st quarter valued at about $37,000. Clearstead Advisors LLC raised its stake in Nature’s Sunshine Products by 16,025.0% during the 4th quarter. Clearstead Advisors LLC now owns 1,935 shares of the company’s stock valued at $42,000 after acquiring an additional 1,923 shares in the last quarter. McIlrath & Eck LLC bought a new stake in Nature’s Sunshine Products during the 1st quarter valued at $48,000. Finally, Raymond James Financial Inc. bought a new stake in Nature’s Sunshine Products during the 2nd quarter valued at $37,000. 79.40% of the stock is currently owned by institutional investors.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.